Načítá se...
Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy
T-cell therapy using genetically engineered T cells modified with either T cell receptor or chi-meric antigen receptor holds great promise for cancer immunotherapy. The concerns about its toxicities still remain despite recent successes in clinical trials. Temporal and spatial control of the enginee...
Uloženo v:
| Vydáno v: | Curr Pharm Des |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Science Publishers
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876919/ https://ncbi.nlm.nih.gov/pubmed/29283058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1381612824666171227222624 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|